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Abstract
Objectives: The estimation of liver volume (LV) has been widely studied in normal liver, the density of
which is considered to be equivalent to 1 kg/l. In cirrhosis, volumetric evaluation and its correlation to liver
mass remain unclear. The aim of this study was to evaluate the accuracy of computed tomography (CT)
scanning to assess LV in patients with cirrhosis.
Methods: Liver volume was evaluated by CT (CTLV) and correlated to the explanted liver weight (LW) in
49 patients. Liver density (LD) and its association with clinical features were analysed. Commonly used
formulae for estimating LV were also evaluated. The real density of cirrhotic liver was prospectively
measured in explant specimens.
Results: Wide variations between CTLV (in ml) and LW (in g) were found (range: 3–748). Cirrhotic livers
in patients with hepatitis B virus infection presented significantly increased LD (P = 0.001) with lower CTLV
(P = 0.005). Liver volume as measured by CT was also decreased in patients with Model for End-stage
Liver Disease scores of >15 (P = 0.023). Formulae estimating LV correlated poorly with CTLV and LW. The
density of cirrhotic liver measured prospectively in 15 patients was 1.1 kg/l.
Conclusions: In cirrhotic liver, LV assessed by CT did not correspond to real LW. Liver density changed
according to the aetiology and severity of liver disease. Commonly used formulae did not accurately
assess LV.
Received 12 October 2012; accepted 11 March 2013
Correspondence
Olivier Scatton, Department of Hepatobiliary and Transplant Surgery, Saint Antoine Hospital, 184 Rue du
Faubourg Saint Antoine, Paris 75012, France. Tel: + 33 1 49 28 25 61. Fax: + 33 1 71 97 01 57.
E-mail: olivier.scatton@sat.aphp.fr
Introduction
Liver volume (LV) has been widely studied and its assessment has
become an essential part of preoperative evaluation in many fields
of hepatic surgery.1–21 Its use in the evaluation and matching of
livers by size prior to liver transplantation1–7,20 and its role as a tool
for predicting postoperative outcomes prior to liver resection9–21
make it an inevitable parameter in modern liver surgery.
The reference standard methods used to assess LV in vivo
include computed tomography (CT) scanning and formulae
based on morphological characteristics. The reliability of meas-
urements obtained in CT has been validated in many studies.22–25
Of the various formulae based on body weight or body surface
area (BSA) that have been developed,24–33 Vauthey’s formula rep-
resents the standard for use in Western countries.27,34
However, LV has been studied mainly in non-cirrhotic
liver.26,30,35 Initial studies measuring LV aimed to establish a rela-
tionship between LV and morphological characteristics (body
weight or BSA), and were mostly based on measurements of
cadaveric healthy livers in autopsy series.26,30,35 When liver density
(LD) was calculated, by dividing liver mass by LV, it was found to
be very near to 1 kg/l.30 Usually, density itself was not measured
and the authors presented only correlation curves showing a
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linear relationship between liver weight and volume.23 Since these
studies, LV has been assumed to equal liver mass.23,24
In the presence of cirrhosis, the evaluation of LV and its corre-
lation to liver mass have been poorly analysed. Clinical and sur-
gical practice show that a cirrhotic liver may be either hypo- or
hypertrophic and, in the context of extended fibrosis, the liver
parenchyma may exhibit variations in density.
The primary aim of this study was to evaluate the correlation
between volume measurements obtained using CT and real liver
mass in patients with cirrhosis undergoing liver transplantation,
and its potential variations. A secondary goal was to evaluate the
applicability and accuracy of the most commonly used formulae
in the setting of cirrhosis. The final goal was to prospectively
measure the density of cirrhotic liver.
Materials and methods
Evaluation of the correlation between LV based on CT
and liver weight using retrospective data
Patient selection
From November 2009 to February 2011 (a 16-month period), all
patients undergoing liver transplantation at the study centre were
registered in this study.Of the 94 patients initially selected, patients
undergoing retransplantation (n = 12), patients who had under-
gone a previous hepatic resection (n = 7) and patients transplanted
for fulminant hepatitis or acute liver failure (n = 2) were excluded.
Pre-transplant patient characteristics, such as aetiology of cir-
rhosis, Model for End-stage Liver Disease (MELD) score and
Child–Pugh class, were recorded. In addition, morphological
characteristics were collected, including weight, height, body mass
index (BMI), and BSA (calculated from weight and height using
the Mosteller formula).36
All of the data collected referred to those valid at the time of
entry to the waiting list so that the time periods that elapsed
between the measurements of the various parameters were
equivalent across the patient cohort.
Explant weighing and pathological characteristics
Explanted cirrhotic livers were weighed at the time of transplan-
tation by pathology staff; other pathological characteristics, such
as parenchymamicro- or macronodular architecture, the presence
and degree of steatosis, cholestasis or haemosiderin deposition,
were noted. Pathology data for three patients were unavailable;
these patients were excluded from the study.
Volume assessment by CT scan
In each patient, LV was measured in a pre-transplant abdominal
CT scan performed at the time of entry to the waiting list. This
volumetric measurement was obtained in all patients by the same
member of the surgical team, who had been previously trained in
the study centre’s radiology department by a radiologist experi-
enced in hepatobiliary radiology.
On each CT slice, the liver shape was delineated manually using
the mouse; the gallbladder, attached ligaments, vena cava and
portal structures were excluded. Semi-automatic ADW 4.5 GE
software (GE Healthcare, Little Chalfont, UK) was used to calcu-
late the total LV on 3 mm – thick slices.
Pre-transplant CT scans were not available for 21 patients
because these patients had been assessed outwith the study centre;
these patients were excluded from analysis.
Estimation of LV using formulae based on
morphological characteristics
Seven recognized formulae were selected and applied in each
patient; results were then compared with LV measurements
obtained using CT scans. The formulae tested were taken from the
work of Schiano et al., Urata et al., Heinemann et al., Vauthey
et al., Yoshizumi et al., Chan et al. and DeLand and North.24–28,31,35
Volume was calculated using either body weight (Schiano et al.,
Vauthey et al., Chan et al.24,27,31) or BSA (Urata et al., Heinemann
et al., Yoshizumi et al., DeLand and North25,26,28,35).
Evaluation of LD in cirrhotic livers in a
prospective cohort
From December 2011 to June 2012, 48 patients underwent liver
transplantation at the study centre. Most of the following data
were collected prospectively at the time of transplantation:
patient age and morphological characteristics (weight, BMI,
BSA), aetiology of cirrhosis and MELD score. Immediately after
liver explantation, the explant was weighed in the operating
room and its volume was measured precisely using the 25 °C
water displacement technique before any fixative was applied
for the pathology examination. Patients undergoing retrans-
plantation or transplantation for fulminant hepatitis were
excluded.
A total of 15 patients were included in this second part of the
study.
Liver density was calculated from the weights and volumes of
explants.
Statistical analysis
Descriptive and comparative statistical analyses were realized
using SPSSVersion 20 (SPSS, Inc., IBMCorp., Armonk,NY,USA).
The correlation between CT-assessed LV (CTLV) and liver
weight (LW) was assessed by linear regression. Liver density was
calculated from CTLV and LW (LD = LW/CTLV).
The correlations between LVs calculated by the different for-
mulae and CTLV were also assessed using linear regression.
Non-parametric tests (Mann–Whitney U-test) were used to
analyse the variations in CTLV and LD depending on the aetiology
of cirrhosis, pathological features and MELD score.
Results
Part 1: evaluation in a retrospective cohort (n = 49)
Population characteristics
A total of 49 patients who underwent a first liver transplantation
between November 2009 and February 2011 at the study centre
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were included in the study. A flow chart of these patients is dis-
played in Fig. 1.
Patient characteristics are represented in Table 1.
Correlation between explant weight and CTLV
Results are displayed in Table 2. The median CTLV was 1298 ml
(range: 530–3126 ml); mean CTLV was 1394  490 ml. Median
LW was 1300 g (range: 600–2500 g); mean LW was 1321 437 g.
The median difference between CTLV (in ml) and LW (in g) was
145, corresponding to a mean variation of 14% (range: 0.4–
38.4%) between the two values. This variation between CTLV and
LW was >20% in 14 of the 49 (28.6%) patients and >10% in 26 of
the 49 (53.1%) patients (Fig. 2).
Correlation between CTLV and LV estimated by formulae
Correlation curves for CTLV and LV measurements obtained
using the various formulae are displayed in Fig. 3.
None of the seven formulae applied showed a satisfactory cor-
relation with CTLV or LW. The correlation coefficients ranged
from 0.16 (Chan et al. formula31) to 0.26 (Heinemann et al.,Yoshi-
zumi et al., DeLand and North formulae26,28,35).
Variations in CTLV and LD according to aetiology of
cirrhosis and severity of liver disease
In cirrhotic liver, the median estimated LD was 0.92 kg/l (range:
0.7–1.6 kg/l); mean LD was 0.97  0.18 kg/l (Table 3).
Median MELD scores did not differ statistically significantly
among the different aetiologies [alcohol-related, hepatitis B virus
(HBV) infection, HCV infection, biliary diseases, non-alcoholic
steatohepatitis (NASH)].
In HBV-infected patients with cirrhosis (n = 5), median CTLV
was significantly lower than in patients without HBV infection
(757 ml versus 1370 ml; P = 0.005) and LD was significantly
increased (1.11 kg/l versus 0.91 kg/l; P = 0.001). In patients with
NASH (n = 5), CTLV tended to be higher (1807 ml versus
94 liver transplantaons
November 2009 to February 2011
49 pa ents
73 eligible paents
12 Retransplanta ons
7 Previous resec ons
2 Fulminant hepa s
3 No pathological data
21 No CT scan available
Figure 1 Flow chart showing patients enrolled in part 1 of the study.
CT, computed tomography
Table 1 Characteristics of the 49 patients analysed retrospectively
Characteristic
Age, years, median (range) 56 (15–69)
Gender, n (%)
Male 31 (63.3%)
Female 18 (36.7%)
Median BSA, m2, median (range) 1.84 (1.37–2.22)
Body weight, kg, median (range) 70 (45–105)
BMI, kg/m2, median (range) 24 (17–36)
Aetiology, n (%)
Alcohol 23 (46.9%)
Hepatitis C virus infection 18 (36.7%)
Hepatitis B virus infection 5 (10.2%)
Biliary diseases 8 (16.3%)
NASH 5 (10.2%)
MELD score, median (range) 15 (6–40)
Time between CT scan and LT, days.
median (range)
122 (1–549)
BSA, body surface area; BMI, body mass index; NASH, non-alcoholic
steatohepatitis; MELD, Model for End-stage Liver Disease; CT, com-
puted tomography; LT, liver transplant.
Table 2 Liver volume measured by computed tomography (CTLV)
and liver weight (LW) in 49 patients
Value
CT liver volume, ml, median (range) 1298 (530–3126)
Liver weight, g, median (range) 1300 (600–2500)
Difference between CTLV (in ml) and
liver weight (in g), median (range)
145 (3–748)
Liver density, kg/1, median (range) 0.92 (0.7–1.6)
0
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Figure 2 Variation between computed tomography liver volume
(CTLV) and liver weight, %
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1293 ml; P = 0.211) and LD lower (0.88 kg/l versus 0.94 kg/l; P =
0.223) than in non-NASH patients, but these differences did not
reach statistical significance. The same trend was observed for
CTLV in patients with and without biliary diseases (1628 ml
versus 1275 ml; P = 0.244). In the NASH group, BMI, BSA and
patient weight were significantly increased in comparison with
those in patients with the other aetiologies (median BMI:
30.5 kg/m2 versus 23.6 kg/m2; P < 0.001); in consequence, LVs
calculated using the various formulae were all significantly
increased (data not shown).
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Figure 3 Correlations between computed tomography liver volume (CTLV) and liver volume (LV) estimated according to seven commonly
used formulae described by (a) Vauthey et al., (b) Urata et al., (c) Heinemann et al., (d) Schiano et al., (e) Yoshizumi et al., (f) DeLand and
North and (g) Chan et al
Table 3 Liver volume measured by computed tomography (CTLV), liver weight and liver density in 49 patients according to aetiology of
cirrhosis and Model for End-stage Liver Disease (MELD) score
CTLV, ml, median
(range)
Liver weight, g,
median (range)
Liver density, kg/1,
median (range)
All patients (n = 49) 1298 (530–3126) 1300 (600–2500) 0.92 (0.70–1.60)
Alcohol-related cirrhosis (n = 23) 1273 (676–2158) 1300 (600–2100) 0.92 (0.72–1.62)
HCV infection (n = 18) 1437 (730–2298) 1425 (700–2000) 0.92 (0.72–1.34)
HBV infection (n = 5) 757 (530–1202)a 830 (600–1950) 1.11 (1.06–1.62)a
NASH (n = 5) 1807 (797–3126) 1600 (800–2500) 0.88 (0.79–1.00)
Biliary diseases (n = 8) 1628 (684–1963) 1550 (600–1900) 0.90 (0.79–0.97)
MELD score > 15 (n = 18) 1198 (530–2146)a 1100 (600–1950)a 0.98 (0.72–1.16)
aP < 0.050, Mann–Whitney U-test.
HCV, hepatitis C virus; HBV, hepatitis B virus; NASH, non-alcoholic steatohepatitis.
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Patients presenting with a MELD score of >15 had a signifi-
cantly lower CTLV compared with patients with MELD scores of
15 (1198 ml versus 1572 ml; P = 0.023).
Part 2: evaluation of cirrhotic LD in a
prospective cohort (n = 15)
Patient characteristics are presented in Table 4. Of the 15 patients,
seven (46.7%) had alcohol-related cirrhosis, four (26.7%) had
biliary diseases, three (20.0%) had HCV cirrhosis, and one (6.7%)
had NASH. The median MELD score was 12 (range: 8–20). The
calculated median LD of cirrhotic liver was 1.09 kg/l (range: 1.07–
1.14 kg/l).
Discussion
This study revealed the discrepancy between the real weight of
cirrhotic liver and cirrhotic liver volume estimated according to
CT scans. Wide variations were found between these two values:
variations were found to exceed 30% in one third of patients and
to exceed 20% in half of the patient population. Obviously, the
volume of cirrhotic liver is not equivalent to its mass. Moreover,
the formulae usually applied to estimate LV based on morpho-
logical characteristics were correlated to neither LV according to
CT evaluation nor LW. Overall, the present experience indicates
that the standard methods used to evaluate LV in patients with
cirrhosis are not reliable. Finally, the prospective evaluation per-
formed in the current study showed that LD was 1.1 kg/l, which
differs from the 1 kg/l usually reported for LD in normal liver.
A firstmain finding of this studywas a significant variation in LV
according to both the aetiology and severity of cirrhosis. Cirrhotic
livers are known to present wide variations in volume and
weight.37–41 Indeed, previous studies found that livers affected by
alcohol-related cirrhosis tend to be hypertrophic,24,41 and livers
affected by HBV infection tend to be hypotrophic.24,39 These
changes may be related to the fibrotic process resulting from
chronic inflammation. The present results confirmed that HBV
cirrhotic livers were significantly lower in volume compared with
livers with cirrhosis of other aetiologies. Interestingly, this atrophy
was also found in severely cirrhotic livers in patients with MELD
scores of >15whatever the aetiology.This latter result highlights the
relationship between the severity of cirrhosis and themorphologi-
cal changes usually seen in advanced liver disease. Although the
methodology used to assess density could be considered question-
able (LV assessed by CT scan and not measured by water displace-
ment), the present study shows that LD was significantly increased
in HBV cirrhosis, confirming that the volume of a liver is not
equivalent to its mass. This latter finding led to the prospective
measurement of LD using the water displacement technique. In
this series, the volumetric assessment of cirrhotic liver did not
correspond to the quantity of parenchyma and consequently
represents a source of under- or overestimation. Interestingly,
patientswith biliary diseases andNASH-related cirrhosis tended to
have higher LVs. This hypertrophy observed in ‘surcharge’ diseases
(fatty surcharge in NASH, or cholestatic surcharge in biliary dis-
eases)may reflect a pathogenesis that differs from that in primarily
hepatocellular diseases (alcohol-related and viral hepatitis).
A second significant finding was the prospective confirmation
that LD differs between patients with and without cirrhosis. In fact,
the complementary measurement of exact LD in patients with cir-
rhosis using water displacement revealed amedian value of 1.1 kg/l.
Previous studies conducted on cadaveric healthy livers or in living
donors in order to evaluate volumetric assessment (by CT scan or
formulae) have always considered LD to be 1 kg/l. Few studies have
consistently calculatedLD.Twoof these studiesmeasured thedensity
of cadaveric healthy livers and found densities of, respectively,
1.04 kg/l (Yu et al., 24 autopsies)30 and 1.08 kg/l (Heinemann et al.,
33 autopsies).26 However, postmortem tissue changes make these
data very difficult to interpret. The study that most reliably deter-
mined LD in healthy livers was conducted by Fu-Gui et al. and based
on 115 right lobe grafts from living donorsmeasured before implan-
tation.33 Liver density was found to be 1.001 kg/l. Finally, LD in
cirrhotic livers has beenpoorly investigated. Indeed,VanThiel et al.23
reported findings in 99 explanted livers in which volume andweight
were measured during transplantation and which demonstrated a
linear relationship between LW and LV (R = 0.99). However, the
authors made no calculation of density and the liver diseases were
mostly (>70%) not ‘primarily hepatocellular’ (viral or alcoholic)
diseases.23 To the present authors’ knowledge, the current study
reports the first prospective measurement of LD in cirrhotic livers.
These results may have important implications in clinical prac-
tice. Indeed, short-term outcomes after liver resection are related
to the quantity of parenchyma retained [i.e. the future liver
remnant (FLR)].12–21 The popularized ‘standardized FLR’ is calcu-
lated from a CT measurement of the FLR and ‘standardized total
Table 4 Characteristics of the prospective patient cohort (n = 15)
Characteristic Value
Median age, years, median (range) 60 (41–69)
Gender, n (%)
Male 12 (80.0%)
Female 3 (20.0%)
BMI, kg/m2, median (range) 23 (17–33)
Aetiology, n (%)
Alcohol-related 7 (46.7%)
Hepatitis C virus infection 3 (20.0%)
Hepatitis B virus infection 0
Biliary diseases 4 (26.7%)
NASH 1 (6.7%)
MELD score, median (range) 12 (8–20)
Liver weight, g, median (range) 1479 (805–1985)
Liver volume, ml, median (range) 1370 (750–1800)
Liver density, kg/1, median (range) 1.09 (1.07–1.14)
BMI, body mass index; NASH, non-alcoholic steatohepatitis; MELD,
Model for End-stage Liver Disease.
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liver volume (TLV)’ which is calculated using the BSA-based
formula: FLR (%) = (FLR volume from CT)/(TLV from for-
mula).19 Cut-off FLR values have been estimated in order to avoid
postoperative liver failure, allowing liver resections to be safer. In
normal liver, Truant et al. proposed a cut-off value of 0.5% for
the ratio of FLR to body weight, which appeared to be more
specific and sensitive in predicting postoperative course after
extended hepatectomy than the ratio of FLR to TLV.42 Finally, in
the setting of liver transplantation, the amount of liver paren-
chyma required for adequate postoperative liver function is based
on the ratio of LW to body weight. The optimal liver quantity
needed represents about 1% of body weight. The MD Anderson
Cancer Center team proposed three FLR benchmarks for safe liver
resection: >20% of TLV in patients with normal liver; >30% of
TLV in patients with diseased liver, and >40% of TLV in patients
with (well-compensated) cirrhosis.14,18,21 All these measurements
are based on LV or were determined only in healthy liver. The
present study showed that these values may not be reliable or
representative of the real quantity and quality of the parenchyma
in patients with cirrhosis. Consequently, volumetric discrepancies
that are related to aetiology and severity may represent a source of
error in the evaluation of the FLR. As in liver transplantation and
liver resection of normal liver, LW rather than LV should be con-
sidered and the fact that the mass of a cirrhotic liver is 1.1 times
higher than its volume should be noted. This refines the evalua-
tion of hepatic function in cirrhosis, which depends on both the
quantity and quality of the parenchyma, and thus introduces LD
as an important, aetiology-related parameter with which to
achieve a better evaluation of liver functional capacity in cirrhosis.
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